AMN Healthcare Services reported that Chief Information and Digital Mark Christopher Hagan acquired 9,331 common shares when restricted stock units vested on October 15, 2026. On the same date, 3,348 shares were withheld for taxes at a reported price of $37.66 per share. The units were granted October 15, 2024 under the AMN Healthcare 2017 Equity Plan. No Rule 10b5-1 plan is reported.
AMN Healthcare Services Inc. Chief Legal Officer Whitney M. Laughlin acquired 4,976 shares of common stock when Restricted Stock Units vested on October 15, 2026. 1,212 shares were withheld for tax purposes at $37.66 per share. The units were granted on October 15, 2024, under the AMN Healthcare 2017 Equity Plan and vest in two tranches on the first and second anniversaries of the grant date, with the grantee providing two periods of credited service.
AMN HEALTHCARE SERVICES INC reported that Chief Legal Officer Whitney M. Laughlin had 498 Restricted Stock Units convert into the same number of shares of common stock on September 15, 2026, upon vesting under the AMN Healthcare 2017 Equity Plan. Of these shares, 122 were withheld at $34.19 per share to cover tax obligations. No Rule 10b5-1 trading plan is reported in connection with these transactions.
Morgan Stanley, through certain reporting units, reports a passive ownership stake in AMN Healthcare Services, Inc. common stock. As of June 30, 2026, the filing shows 2,076,006 shares beneficially owned, representing 5.4% of AMN’s common stock. Morgan Stanley reports no sole voting or dispositive power, with shared voting power over 2,075,030 shares and shared dispositive power over 2,076,006 shares. The disclosure applies only to certain Morgan Stanley operating units, with other units, if any, disaggregated under applicable SEC guidance.
AMN Healthcare Services generated Q2 2026 revenue of $673.2 million, up 2% from $658.2 million a year earlier, and returned to profitability with $21.2 million of net income versus a prior-year loss. For the first half of 2026, revenue rose 52% to $2,051.6 million.
Growth was concentrated in nurse and allied solutions, where revenue nearly doubled to $1,549.3 million driven largely by large-scale labor disruption staffing, while physician and leadership and technology and workforce solutions revenues declined 6% and 15% year-to-date. Consolidated first-half gross margin was 28.0% versus 29.3% a year earlier, as pricing pressure and client losses weighed on technology offerings, partly offset by higher-margin labor disruption work. Operating cash flow more than doubled to $372.5 million, bolstering liquidity; the company ended June 30 with no borrowings on its $450 million revolver and $750 million of senior notes outstanding.
AMN Healthcare Services, Inc. posted second quarter 2026 revenue of $673 million, up 2% from a year earlier and down 51% sequentially following unusually large labor disruption events in the first quarter. Net income was $21 million, or $0.53 per diluted share, compared with a net loss of $116 million, or ($3.02) per share, in Q2 2025. Adjusted diluted EPS rose to $0.77 from $0.30, and adjusted EBITDA was $73 million, a 26% year-over-year increase with a 10.9% margin.
Nurse and Allied Solutions revenue was $422 million, up 11% year over year, helped by travel nurse and allied growth and $25 million of labor disruption revenue. Physician and Leadership Solutions revenue was $165 million, down 6% year over year, while Technology and Workforce Solutions revenue declined 15% to $87 million, with language services at $70 million and vendor management systems at $15 million.
Cash and cash equivalents totaled $362 million at June 30, 2026, against total debt of $750 million, resulting in a 1.5x leverage ratio under the company’s credit agreement. Operating cash flow was ($190 million) for the quarter and $373 million year to date, reflecting the return of client deposits from first-quarter labor disruption events. For the third quarter of 2026, management guides consolidated revenue to $640–$655 million and adjusted EBITDA margin to 6.5%–7.0%.
AMN Healthcare Services director Daphne E. Jones reported compensation-related equity activity and corrected a prior share count. She exercised 8,325 Restricted Stock Units (RSUs) into the same number of shares of AMN common stock, which are held in the Daphne E. Jones Revocable Trust. Following this transaction, the filing states she beneficially owned 16,124 shares of common stock through the trust.
On the same date, Jones received a new grant of 8,304 RSUs under the AMN Healthcare 2025 Equity Plan, each representing one future share of common stock, bringing her direct RSU holdings to 8,304 units. The amendment also notes an earlier Form 4 had overstated her post-transaction ownership by 1,000 shares, and this filing corrects that figure.
AMN Healthcare Services director Mark G. Foletta, through The Foletta Family Trust, reported open-market sales of a total of 3,681 shares of AMN common stock on June 15, 2026. The trust sold 2,000 shares at a weighted average price of $31.069 and 1,681 shares at a weighted average price of $31.067, in multiple trades within disclosed price ranges. Both sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on March 12, 2026. After these transactions, indirect holdings reported for the trust were 19,917 shares in one line and 17,917 shares in another.
AMN Healthcare Services reported a sharp turnaround in Q1 2026, driven by large labor disruption projects. Revenue doubled to $1,378.4 million from $689.5 million, led by nurse and allied solutions, which surged to $1,127.3 million as AMN staffed multiple large-scale labor disruption events.
Net income swung to a profit of $62.2 million, or $1.60 per basic share, compared with a small loss a year earlier. Operating cash flow jumped to $562.5 million, reflecting sizable client deposits and higher segment operating income, and cash and cash equivalents rose to $560.7 million with the revolving credit facility fully repaid.
While nurse and allied solutions grew 173%, physician and leadership solutions revenue declined 6% and technology and workforce solutions fell 15%, pressured by lower locum tenens volume, weaker VMS and language pricing, and the sale of the Smart Square scheduling software. Consolidated gross margin narrowed to 26.8% from 28.7% as mix shifted and technology margins compressed, partly offset by higher-margin labor disruption work.